Phase 2 Chronic Hepatitis B trials recruiting now

All Chronic Hepatitis B trials, every phase

Other phases for Chronic Hepatitis B

Phase 2 Chronic Hepatitis B trials

• A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs
  NCT07069569 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 14 locations
• A Multicenter, Randomized, Open, Parallel-designed Study to Evaluate the Efficacy and Safety of HRS-5635 Injection Alone or in Combination With Other Agents in Patients Treated for Chronic Hepatitis B
  NCT06425341 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (A)
  NCT05769816 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (B)
  NCT05771402 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B
  NCT06263959 · Phase: Phase 2 · Ages: 35 Years to 65 Years · Sex: All (male and female) · 1 location
• A Study to Evaluate AHB-137 Injection in Treatment-naïve Participants With Chronic Hepatitis B
  NCT07635186 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 34 locations
• A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)
  NCT07137910 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 12 locations
• From Fungus to Virus, Investigating the Safety and Efficacy of Terbinafine in Chronic Hepatitis B Patients
  NCT06295328 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Intrahepatic and Peripheral Responses to Imdusiran (AB-729) in Chronic Hepatitis B
  NCT06154278 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study of GST-HG131&141 Tablets Compared With Placebo in Patients With Chronic Hepatitis B
  NCT07709520 · Phase: Phase 2 · Ages: 35 Years to 65 Years · Sex: All (male and female) · 1 location
• TherVacB - A Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis B Vaccine Candidate
  NCT06513286 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 6 locations
• VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B
  NCT06092333 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.